Flavomycin - 8% premix

CAS: 11015-37-5

Ref. 3D-AF145529

Informação sobre produto

• Nome: Flavomycin - 8% premix
• Sinónimos: BambermycinMoenomycin, (2R)-3-{[{[(2R,3R,4R,5S,6S)-3-{[(2S,3R,4R,5S,6R)-3-(acetylamino)-5-{[(2S,3R,4R,5S,6R)-3-(acetylamino)-4-hydroxy-6-methyl-5-({(2R,3R,4S,5R,6S)-3,4,5-trihydroxy-6-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)carbamoyl]tetrahydro-2H-pyran-2-yl}oxy)tetrahydro-2H-pyran-2-yl]oxy}-4-hydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy}methyl)tetrahydro-2H-pyran-2-yl]oxy}-6-carbamoyl-4-(carbamoyloxy)-5-hydroxy-5-methyltetrahydro-2H-pyran-2-yl]oxy}(hydroxy)phosphoryl]oxy}-2-{[(2Z,6E,13E)-3,8,8,14,18-pentamethyl-11-methylidenenonadeca-2,6,13,17-tetraen-1-yl]oxy}propanoic acid (non-preferred name), (2S,3S,4R,5R,6R)-5-{[(2S,3R,4R,5S,6R)-3-(acetylamino)-5-{[(2S,3R,4R,5S,6R)-3-(acetylamino)-4-hydroxy-6-methyl-5-({(2R,3R,4S,5R,6S)-3,4,5-trihydroxy-6-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)carbamoyl]tetrahydro-2H-pyran-2-yl}oxy)tetrahydro-2H-pyran-2-yl]oxy}-4-hydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy}methyl)tetrahydro-2H-pyran-2-yl]oxy}-4-(carbamoyloxy)-6-({[(2R)-2-carboxy-2-{[(2E,6E,13E)-3,8,8,14,18-pentamethyl-11-methylidenenonadeca-2,6,13,17-tetraen-1-yl]oxy}ethoxy](hydroxy)phosphoryl}oxy)-3-hydroxy-3-methyltetrahydro-2H-pyran-2-carboxylic acid (non-preferred name), Flapol, Flavofosfolipol, Flavomycin, Flavophospholipol, Gainpro, Menomycin, Moenomycin, Pharmastim

Descrição

Flavomycin is an antibiotic that belongs to the group of aminoglycosides. It inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit, inhibiting the binding of aminoacyl-tRNA to the A site. Flavomycin has been shown to be active against a range of human pathogens, including Mycobacterium tuberculosis and Salmonella enterica serovar Typhi. Flavomycin acts by binding to the penicillin-binding protein (PBP) in bacterial cells. This prevents peptidyl transferase from linking amino acids together in the formation of proteins, resulting in inhibition of cell growth and eventual cell death.

Flavomycin has been shown to have a high degree of structural similarity with other antimicrobial agents such as amoxicillin-clavulanic acid and salinomycin sodium, which may indicate its potential as a model system for these drugs. Structural analysis has revealed that flavomycin binds

• Marca: Biosynth

Propriedades químicas

• Peso molecular: 1,583.57 g/mol
• Fórmula: C₆₉H₁₀₇N₄O₃₅P
• Pureza: 7 To 9%
• Cor/forma: Powder